5915 S Rainbow Blvd ste 105, Las Vegas, NV 89118, USA
Weight loss - GLP1 Injections
Weight Loss - Semaglutide/Tirzepatide
Onboarding visit consists of reviewing patient's health history, diet/lifestyle habits, and gives the client an opportunity to gather information of weight loss with personalized compounded semaglutide/L-carnitine or tirzepatide/L-carnitine weekly injections. Lab draw performed during visit and treatment started if eligible.
Telehealth available - Patient to have recent labs within 6 months of treatment start
Weight loss with compounded Semaglutide /L-carnitine injections Monthly Cost- $400 for standard dosing. Higher dosing - $500
Includes follow-up visits with licensed provider, medications (Client can opt to stay on $400 plan which is max 1.25mg (0.5mL/week), supplies to inject at home eliminating inconvenient weekly office visits, and follow-up labs.
Weight loss with compounded Tirzepatide/L-carnitine injections Monthly Cost- $575 for standard dosing. Higher dosing - $725
Includes follow-up visits with licensed provider, medications (Client can opt to stay on $575 plan which is max 7.5mg (0.45mL/week), supplies to inject at home eliminating inconvenient weekly office visits, and follow-up labs.
Note: Weight loss achieved at standard dosing and higher dosing optional
Maintenance Program: For those already on compounded Semaglutide or Tirzepatide or for those recently finished
- Semaglutide 0.5mg/0.2mL weekly injection- $200/month
- Tirzepatide 3.34mg/0.2mL weekly injection-$300/month
Patient Treatment Process
We strive to make our patients feel comfortable and cared for during every visit. Treatment process will vary and be client specific but below is the process to get you started with your weight loss services.
Step 1 - Book a free 15-minute phone consultation with one of our licensed providers
Step 2- Have your onboarding visit and have blood work drawn (average 2-3 days to acquire results)
Step 3 - Review lab results with licensed provider to determine eligibility
Step 4 - Pick up medications and injecting supplies to start Semaglutide or Tirzepatide weekly injections in the convenience of your home and without weekly office visits.
What is Semaglutide & Tirzepatide weight loss injections
Semaglutide (the active ingredient in Ozempic) injection is used to treat type 2 diabetes and now FDA approved for obesity. It is used together with diet and exercise to help control your blood sugar, slow down gastric motility and decreasing hunger. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is a once a week injection. Dosage increase will be dependent on clients responses, side effects, and goals.
Tirzepatide (the active ingredient in Mounjaro) injections is used to treat type 2 diabetes and is now FDA approved for obesity. It like Semaglutide is used together with diet and exercise to help control your blood sugar and reduce appetite. Unlike Semaglutide, Tirzepatide is a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This medication leads to greater glycemic control as well as weight reduction. Tirzepatide is a once a week injection. Dosage increase will be dependent on clients responses, side effects, and goals.
*Weight loss - Semaglutide/Tirzepatide Ineligible Candidates: those with normal/below normal BMI, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, Diabetic retinopathy, Multiple endocrine neoplasia type 2, family history of medullary thyroid carcinoma.
Disclaimer
Compounded Semaglutide and Tirzepatide products, often used for weight loss, are not FDA approved and may not be safe of effective. Compounded products vary in potency and quality, and some may contain salt formulations that are not the same active ingredient as in approved drugs. Compounded medications are available when there is a shortage of medication through traditional pharmacies.
Ozempic (semaglutide) and Wegovy (semaglutide) are not compounded medications. Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss as off label use. Wegovy is FDA-approved for weight loss. Mounjaro (Tirzepatide) and Zepbound (Tirzepatide) are not compounded medications. Mounjaro is FDA-approved for type 2 diabetes but may be prescribed for weight loss as off label use. Zpebound is FDA-approved for weight loss. * These medications have recently been removed from the drug shortage list*
